Purchase Order 75N94025P00639
- Not listed
- This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $16,058.50 firm fixed price BPA call contract to Eurofins Discoverx LLC for laboratory testing services. Awarded on June 22, 2017, with an ultimate completion date of September 30, 2017, this contract was issued without a set-aside designation. The work is to be performed in Rockville, Maryland, where NIAAA maintains its headquarters. Eurofins Discoverx LLC, a foreign-owned, for-profit organization specializing in...
- The National Institute on Alcohol Abuse and Alcoholism awarded a Blanket Purchase Agreement (BPA) call contract valued at $3,741.00 to Eurofins Discoverx LLC on November 4, 2016, with completion scheduled for November 3, 2017. This firm fixed-price contract was awarded without set-asides and is to be performed in Bethesda, Maryland. Eurofins Discoverx LLC, a foreign-owned biotech firm specializing in cell-based assays and research reagents, has been registered to receive federal awards since...
- This federal contract award, valued at $17,895.60, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned, for-profit organization. The contract was awarded on a firm fixed-price basis without any set-aside designations. Eurofins Discoverx Corporation, which specializes in providing innovative cell-based assays, reagents, and services to support...
- The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a $15,000 purchase order to Enamine US Inc. to deliver in vitro ADME assays in support of NIAAA's research programs. The firm fixed price contract runs from August 2023 through August 2024 and will be performed by Enamine in West Chester Township, Ohio. No subcontractors or set aside designations were identified. The contract will provide assay services to assist...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at $18,302.40 to Life Technologies Corporation. Under this contract, Life Technologies will provide NIAAA with supplies consisting of an 8-plex mouse proteome panel to support alcohol-related research efforts. Performance will take place in Grand Island, New York over a one...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a firm fixed-price purchase order valued at $122,770 to Life Technologies Corporation for a Luminex xMAP Intelliflex instrument and related accessories and warranties. The award, issued July 10, 2025, is a non-set-aside contract with an ultimate completion date of December 30, 2025. The Luminex xMAP Intelliflex is a multiplex analysis platform used for high-throughput biomedical research applications, supporting NIAAA's...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the National Institutes of Health (NIH), awarded a firm-fixed-price purchase order contract worth $10,122.00 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostic products. The contract is for the delivery of RNAscope HiPlex Probes Assay Kits, which are specialized reagents used for the precise visualization and quantification of RNA biomarkers in cells and tissues. This...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $23,592 purchase order to Life Technologies Corporation for NIAAA - ION REAGENT KITS. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, will deliver ion reagent kits to the NIAAA location in Grand Island, New York under the firm fixed price contract. The...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, awarded a firm-fixed price purchase order contract worth $115,835.00 to Scale Biosciences, Inc., a for-profit organization located in San Diego, California. The contract is for the supply of single cell methylation reagents, which are essential for the NIAAA's epigenomic research. These specialized reagents, manufactured exclusively by Scale Biosciences, are compatible with the National Institutes of Health...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $14,731 firm fixed price purchase order to Eurofins Discoverx Products, LLC for the supply of assay kits. This award, designated as a Total Small Business set aside, was executed on September 19, 2025, with an ultimate completion date of November 19, 2025. The work will be performed at the contractor's facility in Fremont, California. Eurofins Discoverx Products, LLC specializes in cell-based assays, reagents, and contract research services supporting drug discovery and development. The company manufactures and commercializes cell-based assay kits and offers contract development and manufacturing organization (CDMO) and contract research organization (CRO) services. This procurement aligns with the contractor's core competencies and its established history of providing research support to federal agencies including the National Institutes of Health, Department of the Army, and Department of Veterans Affairs, with prior deliverables including target engagement assays and high-throughput screening tools relevant to therapeutic development and disease research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 9/19/25 |